Science Explorer Interactive view Map
Research facility · Huntington · United States

Edwards Comprehensive Cancer Center

edwardsccc.orgROR OpenAlex
Research works
47
▲ 17% vs 2013–17
Citations
556
11.8 per fractional work
Top-10% rate
7.3%
record average 16.5%
Open access
40%
world 28%

Not ranked overall: Edwards Comprehensive Cancer Center is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.30× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.29× its world share, 0 worksImmunology and Micro…Neuroscience: 1.60× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.68× its world share, 0 worksPharmacology, Toxico…Medicine: 3.74× its world share, 9 worksMedicineNursing: 0.76× its world share, 0 worksNursingEconomics, Econometrics and Finance: 1.82× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.7×. Every wedge is a field page.

Which keywords describe research at Edwards Comprehensive Cancer Center?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Prognostic Factors, Breast Cancer, Immunotherapy, Rituximab, Targeted Therapy, Tumor Microenvironment and Clinical Trials.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy7▲ 20×18 topics
  2. Prognostic Factors5▲ 21×10 topics
  3. Breast Cancer3▲ 25×7 topics
  4. Immunotherapy3▲ 11×14 topics
  5. Rituximab3▲ 39×3 topics
  6. Targeted Therapy3▲ 28×5 topics
  7. Cancer3▲ 4.1×12 topics
  8. Clinical Trials2▲ 7.7×4 topics
  9. Tumor Microenvironment2▲ 14×7 topics
  10. Cancer Incidence2▲ 32×3 topics
  11. Molecular Profiling2▲ 37×3 topics
  12. Clinical Practice Guidelines2▲ 7.4×6 topics
  13. Population-Based Study2▲ 70×2 topics
  14. Precision Medicine2▲ 14×5 topics
  15. Biomarkers2▲ 6.3×6 topics
  16. Cancer Risk2▲ 16×6 topics
  17. Lymphoma2▲ 26×2 topics
  18. Metastasis2▲ 12×5 topics
  19. PET Imaging2▲ 19×4 topics
  20. Survival Analysis2▲ 15×5 topics
  21. Classification2▲ 10×2 topics
  22. Gene Expression Profiling2▲ 39×2 topics
  23. Risk Factors2▲ 3.7×7 topics
  24. Therapeutic Targets2▲ 16×3 topics
  25. Metabolic Syndrome2▲ 4.2×7 topics
  26. Radiotherapy2▲ 9.6×6 topics
  27. Genetic Mutations2▲ 6.6×6 topics
  28. Neoadjuvant Therapy2▲ 15×4 topics
  29. Ovarian Cancer2▲ 33×2 topics
  30. Surgical Management2▲ 7.0×7 topics
  31. Chronic Lymphocytic Leukemia1▲ 59×1 topic
  32. Genetic Pathogenesis1▲ 51×1 topic
  33. Genomic Aberrations1▲ 59×1 topic
  34. Hodgkin's Lymphoma1▲ 51×1 topic
  35. Immune Checkpoint Blockade1▲ 52×1 topic
  36. PD-1 and PD-L11▲ 52×1 topic
  37. Prevention1▲ 6.8×3 topics
  38. Genetic Testing1▲ 16×2 topics
  39. Molecular Characterization1▲ 14×4 topics
  40. Prognostic Markers1▲ 25×3 topics

Which research topics does Edwards Comprehensive Cancer Center publish most on?

By volume in 2022–2025: Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Breast Cancer Treatment Studies and HER2/EGFR in Cancer Research.

Cancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksLung Cancer Research Stu…0Lung Cancer Research Studies: 0 fractional worksBreast Cancer Treatment Studies: 0 fractional worksHER2/EGFR in Cancer Rese…0HER2/EGFR in Cancer Research: 0 fractional worksEconomic and Financial I…0Economic and Financial Impacts of Cancer: 0 fractional worksMultiple and Secondary Primary Cancers: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksLung Cancer Diagnosis an…0Lung Cancer Diagnosis and Treatment: 0 fractional worksGlobal Cancer Incidence and Screening: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional works
Cancer ResearchOncologyEconomics and EconometricsEpidemiology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 0 works
  2. 2 Lung Cancer Research Studies Oncology 0 works
  3. 3 Breast Cancer Treatment Studies Cancer Research 0 works
  4. 4 HER2/EGFR in Cancer Research Oncology 0 works
  5. 5 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  6. 6 Multiple and Secondary Primary Cancers Epidemiology 0 works
  7. 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  8. 8 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  9. 9 Global Cancer Incidence and Screening Oncology 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.8%not open60.2%

World: 28% of research is openly available.

with international co-authors14.5%domestic only85.5%

World: 19% is written across borders.

How has Edwards Comprehensive Cancer Center's research output changed?

Output in 2018–2022 was 17% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Huntington

All research institutions in Huntington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.